Summary
Rosetta Genomics, Ltd. (RGL) is a medical device company, based in Israel. The company develops and commercializes new diagnostic and therapeutic products based on group of genes known as microRNAs. It operates through its business segments such as, RG Laboratory Tests, RG Diagnostic Products, RG MicroRNA Technology and RG Therapeutic Products. RGL conducts several diagnostic test development programs in the fields of oncology and women’s health. The company has entered into an agreement with Genetic Technologies Limited for the distribution of Rosetta Genomics' three diagnostic tests. It distributes its products in Australia, New Zealand and Singapore. RGL is headquartered in Rehovot, Israel.
Rosetta Genomics, Ltd. (ROSG) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as M&A, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Genomics Industry in the United States
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Rosetta Genomics, Ltd., Medical Equipment, Deals By Year, 2007 to YTD 2013 5
Rosetta Genomics, Ltd., Medical Equipment Deals By Type, 2007 to YTD 2013 7
Rosetta Genomics, Ltd., Medical Equipment, Deals By Region, 2007 to YTD 2013 8
Rosetta Genomics, Ltd., Medical Equipment, Deals By Market, 2007 to YTD 2013 9
Rosetta Genomics, Ltd., Medical Equipment, Deals Summary, 2007 to YTD 2013 10
Rosetta Genomics, Ltd., Medical Equipment, Deal Details 13
Partnerships 13
Rosetta Genomics To Enter Into Licensing Agreement For microRNA Intellectual Property And Technology 13
Rosetta Enters Into Licensing Agreement For Patents Related To Cancer Applications 14
Rosetta Genomics Enters Into Licensing Agreement With Avatao Biotech 15
Rosetta Genomics Enters Into Licensing Agreement With Roche 16
Rosetta Genomics Amends Co-Marketing Agreement With Precision Therapeutics For miRview mets2 Assays 17
Rosetta Genomics Enters Into Co-Marketing Agreement With Precision Therapeutics For miRview mets2 Assays 18
Rosetta Genomics Enters Into Agreement With Tel Hashomer Medical Research, Infrastructure And Services 20
Rosetta Genomics Enters Into Agreement With Carmel Medical Center 21
Rosetta Genomics Enters Into Distribution Agreement With Genekor 22
Rosetta Genomics Enters Into An Agreement With Genetic Technologies 23
Rosetta Genomics Enters Into Distribution Agreement With Super Religare Labs 24
Warnex Signs Distribution Agreement With Rosetta Genomics 25
Teva Pharma Enters Into An Agreement With Rosetta Genomics 26
Rosetta Genomics Enters Into An Agreement With The University of Texas M. D. Anderson Cancer Center 27
Rosetta Genomics Enters Into Agreement With University Of California 28
Rosetta Genomics Enters Into Agreement With Henry Ford Health System 29
Rosetta Genomics Enters Into Co-Development Agreement With Columbia University Medical Center 30
Rosetta Genomics Enters Into Co-Development Agreement With NYU Langone Medical 31
Rosetta Genomics Enters Into Research Agreement With Columbia University Medical Center 32
Prometheus Labs Signs An Agreement With Rosetta Genomics 33
Equity Offering 34
Rosetta Genomics Files Shelf Registration Statement For Public Offering Of Securities For Up To $75 Million 34
Rosetta Genomics Completes Underwriters' Exercise Of Over-Allotment Option For $4 Million 35
Rosetta Genomics Completes Private Placement Of Shares For $6.6 Million 37
Rosetta Genomics Completes Private Placement Of Shares For $2 Million 39
Rosetta Genomics Completes Private Placement Of Shares For $1.4 Million 40
Rosetta Genomics Completes Private Placement Of Common Stock For $1.5 Million 41
Rosetta Genomics Completes Private Placement For $2.7 Million 43
Rosetta Genomics Completes Registered Direct Offering For $3.3 Million 45
Rosetta Genomics Completes Private Placement For $2.5 Million 47
Rosetta Genomics Completes Registered Direct Offering Of Shares For $5.1 Million 49
Rosetta Genomics Completes Private Placement Of $8 Million 51
Rosetta Genomics Completes IPO For $30 Million 52
Debt Offering 54
Rosetta Genomics Completes Private Placement Of Debentures Due 2013 For $1.75 Million 54
Rosetta Genomics, Ltd. - Key Competitors 55
Key Employees 56
Locations And Subsidiaries 57
Head Office 57
Recent Developments 58
Corporate Communications 58
Oct 11, 2012: Rosetta Genomics Announces Senior Management Changes 58
Jun 06, 2012: Rosetta Genomics Announces Compliance With Continued Listing Requirements Of NASDAQ Capital Market 58
Product News 59
Nov 06, 2012: Rosetta Genomics Receives Final Approval For miRview Lung From NYSDOH 59
Jul 02, 2012: Study Validating Rosetta Genomics' miRview Lung Assay Published In Journal of Molecular Diagnostics 59
Jun 26, 2012: Rosetta Genomics Receives Conditional Approval For miRview Lung From NYSDOH 60
Jun 19, 2012: Rosetta Genomics Secures Medicare Reimbursement Pricing For miRview mets2 60
May 31, 2012: Rosetta Genomics To Demonstrate Clinical Data Of miRview lung At ASCO 2012 60
May 31, 2012: Rosetta Genomics To Demonstrate Clinical Data Of miRview mets2 Assay At ASCO 2012 61
May 25, 2012: Rosetta Genomics Reports Data Demonstrating Ability Of miRview mets² To Identify Tumor Tissue Origin In Patients With CUP 61
Mar 20, 2012: Study Published In International Journal Of Oncology Shows Potential For microRNAs To Determine Risk Of Recurrence In Colorectal Cancer 62
Product Approvals 63
Nov 06, 2012: Rosetta Genomics Receives Final Approval For miRview Lung From NYSDOH 63
Jun 26, 2012: Rosetta Genomics Receives Conditional Approval For miRview Lung From NYSDOH 63
Clinical Trials 64
Jul 02, 2012: Study Validating Rosetta Genomics' miRview Lung Assay Published In Journal of Molecular Diagnostics 64
May 25, 2012: Rosetta Genomics Reports Data Demonstrating Ability Of miRview mets² To Identify Tumor Tissue Origin In Patients With CUP 64
Mar 20, 2012: Study Published In International Journal Of Oncology Shows Potential For microRNAs To Determine Risk Of Recurrence In Colorectal Cancer 65
Appendix 67
Methodology 67
About GlobalData 67
Contact Us 67
Disclaimer 67
List of Tables
Rosetta Genomics, Ltd., Medical Equipment, Key Facts, 2011 1
Rosetta Genomics, Ltd., Medical Equipment, Deals By Year, 2007 to YTD 2013 1
Rosetta Genomics, Ltd., Medical Equipment, Deals By Region, 2007 to YTD 2013 1
Rosetta Genomics, Ltd., Medical Equipment, Deals By Market, 2007 to YTD 2013 1
Rosetta Genomics, Ltd., Medical Equipment, Deals Summary, 2007 to YTD 2013 1
Rosetta Genomics, Ltd., Medical Equipment, Deals By Year, 2007 to YTD 2013 6
Rosetta Genomics, Ltd., Medical Equipment Deals By Type, 2007 to YTD 2013 7
Rosetta Genomics, Ltd., Medical Equipment, Deals By Region, 2007 to YTD 2013 8
Rosetta Genomics, Ltd., Deals By Market, 2007 to YTD 2013 9
Rosetta Genomics, Ltd., Medical Equipment, Deals Summary, 2007 to YTD 2013 10
Rosetta Genomics To Enter Into Licensing Agreement For microRNA Intellectual Property And Technology 13
Rosetta Enters Into Licensing Agreement For Patents Related To Cancer Applications 14
Rosetta Genomics Enters Into Licensing Agreement With Avatao Biotech 15
Rosetta Genomics Enters Into Licensing Agreement With Roche 16
Rosetta Genomics Amends Co-Marketing Agreement With Precision Therapeutics For miRview mets2 Assays 17
Rosetta Genomics Enters Into Co-Marketing Agreement With Precision Therapeutics For miRview mets2 Assays 18
Rosetta Genomics Enters Into Agreement With Tel Hashomer Medical Research, Infrastructure And Services 20
Rosetta Genomics Enters Into Agreement With Carmel Medical Center 21
Rosetta Genomics Enters Into Distribution Agreement With Genekor 22
Rosetta Genomics Enters Into An Agreement With Genetic Technologies 23
Rosetta Genomics Enters Into Distribution Agreement With Super Religare Labs 24
Warnex Signs Distribution Agreement With Rosetta Genomics 25
Teva Pharma Enters Into An Agreement With Rosetta Genomics 26
Rosetta Genomics Enters Into An Agreement With The University of Texas M. D. Anderson Cancer Center 27
Rosetta Genomics Enters Into Agreement With University Of California 28
Rosetta Genomics Enters Into Agreement With Henry Ford Health System 29
Rosetta Genomics Enters Into Co-Development Agreement With Columbia University Medical Center 30
Rosetta Genomics Enters Into Co-Development Agreement With NYU Langone Medical 31
Rosetta Genomics Enters Into Research Agreement With Columbia University Medical Center 32
Prometheus Labs Signs An Agreement With Rosetta Genomics 33
Rosetta Genomics Files Shelf Registration Statement For Public Offering Of Securities For Up To $75 Million 34
Rosetta Genomics Completes Underwriters' Exercise Of Over-Allotment Option For $4 Million 35
Rosetta Genomics Completes Private Placement Of Shares For $6.6 Million 37
Rosetta Genomics Completes Private Placement Of Shares For $2 Million 39
Rosetta Genomics Completes Private Placement Of Shares For $1.4 Million 40
Rosetta Genomics Completes Private Placement Of Common Stock For $1.5 Million 41
Rosetta Genomics Completes Private Placement For $2.7 Million 43
Rosetta Genomics Completes Registered Direct Offering For $3.3 Million 45
Rosetta Genomics Completes Private Placement For $2.5 Million 47
Rosetta Genomics Completes Registered Direct Offering Of Shares For $5.1 Million 49
Rosetta Genomics Completes Private Placement Of $8 Million 51
Rosetta Genomics Completes IPO For $30 Million 52
Rosetta Genomics Completes Private Placement Of Debentures Due 2013 For $1.75 Million 54
Rosetta Genomics, Ltd., Key Competitors 55
Rosetta Genomics, Ltd., Key Employees 56
List of Figures
Rosetta Genomics, Ltd., Medical Equipment, Deals by Type, 2007 to YTD 2013 1
Rosetta Genomics, Ltd., Medical Equipment, Deals By Year, 2007 to YTD 2013 6
Rosetta Genomics, Ltd., Medical Equipment, Deals by Type, 2007 to YTD 2013 7
Rosetta Genomics, Ltd., Medical Equipment, Deals By Region, 2007 to YTD 2013 8
Rosetta Genomics, Ltd., Medical Equipment, Deals by Market, 2007 to YTD 2013 9
